Result : 227

Living with… Kawasaki disease

 Alexandre Belot, Raphaël Darbon. June 2025, page 87

Emergency treatment of acute cerebral ischemia

Five complementary strategies increase disability - and dependency - free survival after acute cerebral ischemia: - stroke unit care, independent on age, severity, type of stroke, and treatment; -...
 Didier Leys, Charlotte Cordonnier. November 2025, page 6

Management of neuropathic pain: Don’t lose hope!

Neuropathic pain represents a major challenge in the diagnosis and initiation of treatment. This article provides an overview of its definition, epidemiology, and common etiologies. Current...
 Emmanuel Nolot, Xavier Moisset, Nadine Attal. November 2025, page 12

Press review

 Francois Mallordy. November 2025, page 20

The skin, mirror of the soul: an anthropology of tattoos

 Philippe Charlier. November 2025, page 22

Special features of ANCA-associated vasculitides

Necrotizing vasculitis associated to antineutrophil cytoplasmic antibodies (ANCA) are one of the subgroups of vasculitis affecting small-sized vessels. Fibrinoid necrosis of the vascular wall is...
 Loïc Guillevin. November 2025, page 27

Epidemiology and risk factors of ANCAassociated vasculitides

ANCA-associated vasculitides (AAV) are a group of small-vessel vasculitides including microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), and eosinophilic granulomatosis with...
 Lucas Pacoureau, Maxime Beydon, Benjamin Terrier, Yann Nguyen. November 2025, page 34

Recent developments in the treatment of ANCA-associated vasculitides

The treatment of antineutrophil cytoplasm antibody-associated (ANCA) vasculitis is based on induction therapy to achieve remission, followed by maintenance therapy to prevent relapse. Management...
 Xavier Puéchal. November 2025, page 43

Functional neurological disorders

Functional Neurological Disorders (FND) are symptoms associated with dysfunctions in brain networks, often triggered by physical and/or psychological traumatic factors in vulnerable individuals....
 Béatrice Garcin. November 2025, page 60

Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?

Psychedelics, long marginalized, are now gaining renewed interest in psychiatry for their therapeutic potential. Substances
like psilocybin, LSD, and MDMA are being studied for treating...
 Michel Sabé, Federico Seragnoli, Louise Penzenstadler, Gabriel Thorens. November 2025, page 69

Tobacco in films and smoking among young people

The presence of tobacco in films and TV series remains widespread, despite its proven impact on the initiation of smoking among young people. In addition to films, platforms massively distribute...
 Gérard Peiffer ,  Nathalie Lajzerowicz ,  Olivier Galera ,  Jean Perriot ,  Emmanuel Ricard ,  Karine Gallopel-Morvan . April 2026, page 8

Dying, but not too soon: analysis of changes in life expectancy

 Philippe Charlier . April 2026, page 14

Venous diseases of the liver: what are we talking about?

Vascular diseases of the liver include damage to arterial and venous vessels, both hepatic and perihepatic. The main venous forms are Budd-Chiari syndrome (BCS), portal vein thrombosis (PVT) and...
 Audrey Payancé  ,  Juliette Soret-Dulphy . April 2026, page 22

Budd-Chiari syndrome

Budd-Chiari syndrome is a rare condition characterized by obstruction of hepatic venous drainage, ranging from hepatic venules to the terminal part of the inferior vena cava. A thorough etiological...
 Magdalena Meszaros ,  Christophe Bureau . April 2026, page 31

Small liver vessels disorders

Small liver vessels disorders are a heterogeneous group of rare diseases that can affect the portal venules, the hepatic sinusoids, the centri-lobular veins, or the hepatic arteries. The most...
 Lucile Moga ,  Pierre-Emmanuel Rautou . April 2026, page 40

Portal vein thrombosis and mesenteric venous ischemia

Portal vein thrombosis (PVT) in the absence of underlying chronic liver disease is a rare disease and is frequently associated with prothrombotic factors. In patients with cirrhosis, the frequency...
 Cyprien Gayat ,  Alexandre Nuzzo  ,  Laure Elkrief  . April 2026, page 44

Vein and sinusoidal diseases of the liver: 10 key messages

Aurélie Plessie. April 2026, page 60

Viral hepatitis and pregnancy

The event of pregnancy, the risks of obstetrical complications and vertical transmission will vary according to the type of viral hepatitis. Hepatitis A is transmitted via feacal-oral transmisson,...
 Imane Ben M'Barek ,  Jeanne Sibiude ,  Élise Bouthry . April 2026, page 71

Borderline personality disorder

Borderline Personality Disorder (BPD) is common, affecting 2 to 6 % of the general population, with a high prevalence in psychiatric settings. It is characterized by emotional, relational...
 Deborah Ducasse ,  Émilie Olié . April 2026, page 81

Acute inflammatory polyradiculoneuritis (Guillain-Barré syndrome)

 Guillaume Nicolas ,  Djillali Annane ,  David Orlikowski . April 2026, page 88

Metabolic dysfunction associated steatohepatitis, epidemiology and definitions: from steatosis to cirrhosis

A recent change in terminology proposed by scientific societies replaces the term NAFLD (non-alcoholic fatty liver disease) with the term MASLD (metabolic dysfunction associated steatotic liver...
 Raluca Pais. September 2026, page 14

Diagnostic approach for metabolic dysfunction associated steatotic liver disease

Metabolic dysfunction associated steatotic liver disease (MASLD) is a systemic disease affecting the liver. The diagnostic approach consists of the identification of hepatic steatosis, the...
 Lucia Parlati, Charlotte Mouliade, Stanislas Pol. September 2026, page 19

FIB-4: a simple blood test to identify patients at risk of liver complications

 Jérôme Boursier, Frédéric Oberti. September 2026, page 24

Current and future medical treatments for metabolic dysfunction-associated steatohepatitis

Drug treatment of metabolic dysfunction-associated steatotic liver disease (MASLD) is undergoing a revolution. The fight against cardiovascular risk factors, the optimization of the treatment of...
 Rodolphe Anty, Marwin A Farrugia. September 2026, page 26

The role of bariatric surgery and endoscopy in the management of MASLD

The epidemic of metabolic dysfunction-associated steatotic liver disease (MASLD), amplified by shifting dietary habits and increasing sedentary lifestyles, has elevated metabolic...
 Nawel Chouraqui, Guillaume Lassailly. September 2026, page 36

Steatosis and steatohepatitis: a risk factor for complications after liver resection

Metabolic dysfunction-associated steatotic liver disease (MASLD) and its inflammatory form, metabolic dysfunction-associated steatohepatitis (MASH), have become common clinical conditions in...
 Karim Boudjema, Fabien Robin, Heithem Jeddou, Pauline Houssel-Debry. September 2026, page 40

Acquired hemophilia A

 Louis Hebraud, Olivier Fain, Ambroise Le Pogam. September 2026, page 48